ロード中...
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most eff...
保存先:
| 出版年: | Virol Sin |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Singapore
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779898/ https://ncbi.nlm.nih.gov/pubmed/33394351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12250-020-00327-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|